[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100514638":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":38,"locations":47,"responsibleParty":67,"collaborators":26,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":26,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":26,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":26,"overallStatus":50,"whyStopped":26,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Hospital for Special Surgery, New York","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Adductor Canal Catheter (ACC) - Interventional","EXPERIMENTAL","Patients will received the an adductor canal catheter that continuously infuses numbing medication to their operative leg for 50 hours post-surgery.\n\nPatients will also communicate with their pain doctor via the Diagnotes application while the catheter is in place.",[13],"Device: ambIT pump with catheter",{"label":15,"type":16,"description":17,"interventionNames":18},"Adductor Canal Block (ACB) - Control","SHAM_COMPARATOR","Patients will received the a sham adductor canal catheter that is attached to their operative leg for 50 hours post-surgery.\n\nPatients will also communicate with their pain doctor via the Diagnotes application while the catheter is in place.",[19],"Device: ambIT pump with sham catheter",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","ambIT pump with catheter","0.2% ropivacaine will be infused through a catheter pump at a rate of 10 ml\u002Fhr, 600 ml reservoir.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"ambIT pump with sham catheter","sham catheter with no infusion",[15],[32,35],{"name":33,"affiliation":5,"role":34},"Stavros Memtsoudis, MD\u002FPhD","PRINCIPAL_INVESTIGATOR",{"name":36,"affiliation":5,"role":37},"Jashvant Poeran, MD\u002FPhD","STUDY_DIRECTOR",[39,44],{"name":40,"role":41,"phone":42,"phoneExt":26,"email":43},"Pa Thor, PhD","CONTACT","646-797-8535","thorp@hss.edu",{"name":33,"role":41,"phone":45,"phoneExt":26,"email":46},"212-606-1036","memtsoudiss@hss.edu",[48],{"facility":49,"status":50,"city":51,"state":51,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"Hospital for Special Surgery","RECRUITING","New York","10021","United States","US",{"type":56,"coordinates":57},"Point",[58,59],-74.00597,40.71427,{"lat":59,"lon":58},[62,66],{"name":63,"role":41,"phone":64,"phoneExt":26,"email":65},"Justas Lauzadis, PhD","212-774-2946","lauzadisj@hss.edu",{"name":40,"role":41,"phone":42,"phoneExt":26,"email":26},{"type":68,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100514638","enhanced-recovery-after-major-surgery-and-chronic-pain-for-total-knee-arthroplasty-100514638",false,"NCT05981105","Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty","Expanding the Peri-operative Surgical Home Model: ERAS TKR With a Transitional Pain Service (TeleTPS) - Continuous Adductor Canal Catheter Versus Adductor Canal Block for Total Knee Arthroplasty, a Randomized Double-blinded Controlled Trial.","Inclusion Criteria:\n\n* Patients with osteoarthritis scheduled for a primary total knee arthroplasty with a participating surgeon\n* Age 18 to 75 years\n* Planned use of regional anesthesia\n* Ability to follow study protocol\n* English speaking (secondary outcomes include questionnaires validated in English only)\n* Patients of participating surgeons: Drs. Mayman, Jerabek, Westrich, Su, Della Valle, Alexiades\n* Lives within one hour of the hospital\n* Has a smartphone\n\nExclusion Criteria:\n\n* Hepatic or renal insufficiency\n* Younger than 18 years old and older than 65\n* Patients undergoing general anesthesia\n* Allergy or intolerance to one of the study medications\n* BMI \\> 40\n* Diabetes\n* ASA of III,IV\n* Chronic gabapentin\u002Fpregabalin use (regular use for longer than 3 months)\n* PCS \\> 30\n* Chronic opioid use (taking opioids for longer than 3 months, or daily oral morphine equivalent of \\>5mg\u002Fday for one month)\n* Patients with severe valgus deformity or flexion contracture\n* Patients unable to follow home catheter instructions and unwilling to go home with an infusing catheter\n* Patients who have no home caregivers in the event if a catheter is to be sent home with the patient\n* Patients with planned stay at rehab facility","ALL","18 Years","75 Years",{"count":80,"type":81},64,"ESTIMATED","INTERVENTIONAL",[84],"NA","The goal of this interventional clinical trial is to assess opioid consumption 24-48 hrs post anesthesia block among patients undergoing total knee arthroplasty. The main question it aims to answer is:\n\n1\\. Is there a difference in opioid consumption 24-48 hours post block administration among patients that receive an adductor canal catheter (ACC) versus adductor canal block (ACB)?\n\nParticipants will be:\n\n* Randomized to receive an adductor canal catheter (ACC) or a sham adductor canal catheter.\n* Asked to use the Diagnotes application to communicate with the pain doctor while the catheter is in place.\n* Follow up for up to 6 months post-operation. Researchers will compare the interventional group (ACC) to the control group (sham ACC + ACB) to see if there is difference in opioid consumption and chronic pain at 6 months post-operation.",[87,88,89,90],"Chronic Pain","Opioid Use","Adductor Canal Block","Total Knee Arthroplasty","2026-01-14",{"date":93,"type":94},"2026-01-15","ACTUAL",{"date":96,"type":94},"2023-06-12",{"date":98,"type":81},"2027-01-01",{"name":5,"class":6},1]